Health
Common medicines could lead to cancer patients’ deaths – Ballina Shire Advocate
Cancer patients are more likely to die of their disease if they use common antacids bought at the chemist at the same time as immunotherapy treatments.
Cancer patients are more likely to die of their disease if they use common antacids at the same time as immunotherapies a groundbreaking Australian study has found.
Flinders University researchers found bladder cancer patients using antacids called proton pump inhibitors (PPIs) were more likely to have their cancer progress and were less likely to respond to the breakthrough immunotherapy cancer treatment atezolizumab than those not using antacids.
The reason is the antacids change the patient…
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
General14 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
General10 hours agoInternal Revenue Service starts cutting 20,000 workers